Antagonists acting at multiple prostaglandin receptors for the treatment of inflammation
Abstract:
Compounds, processes for their preparation, pharmaceutical compositions containing such compounds and their use in treating therapeutic conditions, in particular conditions mediated by the action of ligands on the FP, DP, EP1, EP4, IP, DP1, FP and TP prostaglandin (PG) receptors thereby providing a general anti-inflammatory response.
Information query
Patent Agency Ranking
0/0